| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/19/1993 | CA2129517A1 Recombinant gibberellin dna and uses thereof |
| 08/19/1993 | CA2129370A1 Protease-resistant thrombomodulin analogs |
| 08/19/1993 | CA2129351A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
| 08/19/1993 | CA2129036A1 Ligands for improving metal chelate formation kinetics |
| 08/19/1993 | CA2129034A1 Mycobacterial species-specific reporter mycobacteriophages |
| 08/19/1993 | CA2129033A1 Radiolabelled peptide compounds |
| 08/19/1993 | CA2129032A1 Phenylalanine analogs of bombesin |
| 08/19/1993 | CA2128698A1 Feline infectious peritonitis vaccine and method of preparation |
| 08/19/1993 | CA2107343A1 Novel hexapeptidic derivatives, process for the preparation thereof and use thereof as medicaments |
| 08/19/1993 | CA2106854A1 Extract of bacterial macromolecules, a process for its preparation and a pharmaceutical composition containing the same |
| 08/19/1993 | CA2089541A1 Selective removal of n-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1 |
| 08/18/1993 | EP0556160A2 Insecticidal toxins from plectreurys tristis |
| 08/18/1993 | EP0556124A1 New peptide derivatives, process to prepare them and their use as medicaments |
| 08/18/1993 | EP0556106A2 Antibody binding to human aldose reductase and its uses |
| 08/18/1993 | EP0556083A1 Process for the production of biologically active substances from milk and related raw materials |
| 08/18/1993 | EP0555989A1 TGF-beta induced gene and protein |
| 08/18/1993 | EP0555894A1 Whooping cough vaccine |
| 08/18/1993 | EP0555880A2 The CD40CR receptor and ligands therefor |
| 08/18/1993 | EP0555785A1 Smooth muscle mitogen and DNA coding therefor |
| 08/18/1993 | EP0555435A1 DNA SEQUENCE ENCODING BOVINE $g(a)-LACTALBUMIN AND METHODS OF USE |
| 08/18/1993 | EP0555425A1 Antibodies to streptolysin o derivatives and variants |
| 08/18/1993 | EP0555405A1 Specific detection of antibodies to human t-cell leukemia viruses |
| 08/18/1993 | EP0555397A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 08/18/1993 | EP0555385A1 Agents and methods for binding to elam-1 |
| 08/18/1993 | EP0555370A1 Methods and applications for efficient genetic suppressor elements |
| 08/18/1993 | EP0555363A1 Identification of a suppressor of atherogenic apolipoprotein |
| 08/18/1993 | EP0555336A1 Homobifunctional agents for coupling enzymes and the like to antibodies and the like. |
| 08/18/1993 | EP0555328A1 Platelet aggregation inhibitors |
| 08/18/1993 | EP0555291A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 08/18/1993 | EP0555286A1 Cell growth inhibitors |
| 08/18/1993 | EP0555205A1 Dna encoding a growth factor specific for epithelial cells |
| 08/18/1993 | EP0555201A1 Recombinant dna coding for bacillus thuringiensis endotoxin |
| 08/18/1993 | EP0542897A4 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors |
| 08/18/1993 | EP0425591B1 Polymer compositions |
| 08/18/1993 | EP0425482B1 Human insulin analogs and preparations containing them |
| 08/18/1993 | CN1075334A Reconstitued body vaccine and method of prepn. thereof |
| 08/18/1993 | CA2085502A1 Human neuronal beta subunits of voltage-operated calcium channels and the use thereof |
| 08/17/1993 | US5237057 Monitoring drug abuse |
| 08/17/1993 | US5237056 Polypeptides; central nervous sytem |
| 08/17/1993 | US5237053 Vaccines containing flagellar antigens |
| 08/17/1993 | US5237052 Useful as componetnts of acellular whooping cough vaccines |
| 08/17/1993 | US5237051 Purified enterotoxin receptor protein |
| 08/17/1993 | US5237050 Bacterial plasmin receptors as fibrinolytic agents |
| 08/17/1993 | US5236903 Polypeptide comprising repeated cell-adhesive core sequences |
| 08/17/1993 | US5236898 Hirudin derivative |
| 08/17/1993 | US5236843 Gene encoding a nematode-active toxin cloned from a Bacillus thuringiensis isolate |
| 08/17/1993 | US5236836 Catalyst for the hydrolysis of peptide bond in vasoactive intestinal peptide |
| 08/17/1993 | US5236834 Isolating gene for protein; constructing nucleotide corresponding to DNA coding region; medical diagnosis |
| 08/17/1993 | US5236829 Method of producing monokine induced by gamma interferon |
| 08/17/1993 | US5236828 Genetic engineering |
| 08/17/1993 | US5236825 Complexing |
| 08/17/1993 | US5236694 19f labelled dextrans and antibodies as nmr imaging and spectroscopy agents |
| 08/16/1993 | EP0652951A4 Gdf-1. |
| 08/15/1993 | WO1993015753A1 Remedy for airway diseases |
| 08/15/1993 | CA2108277A1 Preparation for the therapy of respiratory tract diseases |
| 08/13/1993 | WO1993015759A1 Autoantibody assay and usage in the control of human disease |
| 08/13/1993 | CA2129895A1 Autoantibody assay and usage in the control of human disease |
| 08/13/1993 | CA2089342A1 Peptidic derivatives, process for the preparation thereof and application as drugs of said novel derivatives |
| 08/12/1993 | DE4204694A1 Verfahren zur gewinnung von hochreinem, virusinaktiviertem faktor viii mittels anionenaustauscher-chromatographie Process for the recovery of high purity virus-inactivated factor viii by anion exchange chromatography |
| 08/12/1993 | CA2089247A1 Small peptide and pseudopeptide amides inhibiting the proliferation of small-cell and epithelial-cell lung cancer cells |
| 08/11/1993 | EP0555135A1 Process for preparing highly purified fibrinogen |
| 08/11/1993 | EP0554887A1 The use of mammalian liver extract for the manufacture of a medicament to treat presenile or senile dementia |
| 08/11/1993 | EP0554708A1 Thioether conjugates |
| 08/11/1993 | EP0554670A2 Specific antibodies against activated platelets, their production and applications in diagnostics and therapeutics |
| 08/11/1993 | EP0554634A1 Stabilized pharmaceutical composition comprising non-glycosylated, reduced, recombinant human IL-2 and process to prepare it |
| 08/11/1993 | EP0554624A1 Oligonucleotides, oligopeptides and determination system of HCV antibody subtype |
| 08/11/1993 | EP0554570A2 Stable fibrinogen solution |
| 08/11/1993 | EP0554414A1 Method for producing a subunit vaccine against the canine parvovirus and other related viruses |
| 08/11/1993 | EP0554401A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 08/11/1993 | EP0554389A1 Molecular clones of hiv-1 and uses thereof |
| 08/11/1993 | EP0554376A1 Dna construct for providing rna therapy |
| 08/11/1993 | EP0554374A1 Production and use of tracheal antimicrobial peptides |
| 08/11/1993 | EP0554344A1 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 08/11/1993 | EP0554318A1 A solid surface coated with a hydrophilic outer layer with covalently bonded biopolymers, a method of making such a surface, and a conjugate therefor |
| 08/11/1993 | EP0507870A4 Polyhemoglobin stabilized by purine derivatives and glutathione |
| 08/11/1993 | EP0307402B1 Production of m-csf |
| 08/11/1993 | EP0295287B1 Method for the production of porcine growth hormone using a synthetic gene in yeast cells |
| 08/11/1993 | EP0218651B1 A dna sequence |
| 08/11/1993 | EP0205555B1 Serine protease inhibitors and methods for isolation of same |
| 08/11/1993 | EP0194276B1 Production of chimeric antibodies |
| 08/11/1993 | CN1075148A Amplification gene of megakaryocyte |
| 08/10/1993 | US5235049 Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1 |
| 08/10/1993 | US5235043 Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins |
| 08/10/1993 | US5235042 Purified, angiogenic and releasable from heparin, with which it complexes, by salt elution; cationic, culture product from hepatoma or chondrosarcoma cells |
| 08/10/1993 | US5235041 Lysing; separation of solid material, washing and extraction; high temperature |
| 08/10/1993 | US5235039 Substrates for hiv protease |
| 08/10/1993 | US5235038 Deletion and substitution analogues of melittin peptide |
| 08/10/1993 | US5235036 Crf analogs |
| 08/10/1993 | US5235033 Alpha-morpholino ribonucleoside derivatives and polymers thereof |
| 08/10/1993 | US5234991 Capable of fixing thereto biological macromolecules |
| 08/10/1993 | US5234912 Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof |
| 08/10/1993 | US5234911 Antiinflammatory agents |
| 08/10/1993 | US5234910 Acid inhibitor of bacterial origin |
| 08/10/1993 | US5234907 Bronchodilator agent |
| 08/10/1993 | US5234905 Soluble CD4 molecules modified to prolong circulating half-life |
| 08/10/1993 | US5234903 A deoxygenated, reduced hemoglobin conjugated to a polyoxyalkylene glycol; synthetic blood; oxygen transport; extended half-life; nontoxic |
| 08/10/1993 | US5234839 Compositions for detecting ras gene proteins and cancer therapeutics |
| 08/10/1993 | US5234834 Constructs for expression of monellin in plant cells |
| 08/10/1993 | US5234822 Diagnosis, therapy, vaccines |
| 08/10/1993 | CA1321282C Parathyroid hormone antagonists |